ABOUT US
Torqur AG is a Swiss biotech company revolutionizing the treatment landscape for actinic keratosis (AK).
As a part of the Swiss Rockets group of companies, Torqur AG benefits from the support of its parent company Swiss Rockets AG, a well-established biotech incubator and accelerator, driving innovation at every stage of development.
TORQUR PIPELINE:
DISCOVERY
PRECLINICAL
RESEARCH*
PHASE I
CLINICAL TRIAL
PHASE II
CLINICAL TRIAL
PHASE III
CLINICAL TRIALS
COMMERCIAL
Bimiralisib
Small molecule used topically in the treatment of AK
Bimiralisib
Small molecule used orally in various cancer treatments
Download Our
Company Presentation
your name
your email
organization name